TCL Archive FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza December 26, 2014
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive PR firm Ketchum serves two clients on Medicare issues: CMS and ASCO. HHS policy officials weren’t told about potential conflict, department spokesman says. September 24, 2004
TCL Archive NIH Reauthorization Lost In The Shuffle As Congress Adjourns; NCI Budget $1.723 Bil. November 2, 1990
TCL Archive NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel October 17, 1980
